Table 4.
Sales of 12-week treatment regimens of nicotine replacement therapy, bupropion, and varenicline in India and Kerala from March 2013 – February 2014.
| Medication | India | Kerala | ||||||
|---|---|---|---|---|---|---|---|---|
| Treatment regimens sold (n) | Sales* | Treatment regimens sold (n) | Sales* | |||||
| Indian rupees | US dollars | Indian rupees | US dollars | |||||
| Nicotine replacement therapy | 166,424 | 354,137,400 | 5,705,268 | 7,493 | 16,089,625 | 259,209 | ||
| Nicotine gum 2 mg | 70,482 | 132,988,167 | 2,142,482 | 2,952 | 5,463,745 | 88,023 | ||
| Nicotine gum 4 mg | 95,942 | 221,149,233 | 3,562,786 | 4,541 | 10,625,880 | 171,186 | ||
| Bupropion† | 80,795 | 64,084,682 | 1,032,425 | 6,403 | 4,959,129 | 79,893 | ||
| 100 mg | 53 | 75,214 | 1,212 | – | – | – | ||
| 150mg SR | 33,900 | 31,105,345 | 501,117 | 2,288 | 2,139,681 | 34,471 | ||
| 150 mg XL | 35,055 | 20,789,021 | 334,918 | 3,273 | 1,942,851 | 31,300 | ||
| 300 mg SR | 219 | 104,364 | 1,681 | – | – | – | ||
| 300 mg XL | 11,567 | 12,010,739 | 193,497 | 842 | 876,597 | 14,122 | ||
| Varenicline | 6051 | 58,451,366 | 941,670 | 196 | 2,020,417 | 32,550 | ||
| Starter‡ | – | 8,850,275 | 142,581 | – | 764,774 | 12,321 | ||
| Maintenance | 4981 | 29,423,635 | 474,024 | 191 | 1,128,180 | 18,175 | ||
| 0.5 mg‡ | – | 6,264,814 | 100,928 | – | 60,127 | 969 | ||
| 1 mg | 1070 | 13,912,641 | 224,137 | 5 | 67,336 | 1,085 | ||
| Total | 253,270 | 476,673,447 | 7,679,363 | 14,092 | 23,069,170 | 371,652 | ||
*
The International Monetary Fund exchange rate for February 28, 2014 was used: 62 Indian rupees to 1 US dollar.
†
Bupropion is also used for other indications such as major depressive disorder so these figures are likely overestimates.
‡
Varenicline starter and maintenance packs are used together; 0.5 mg and 1 mg packs are used together.